The Uromigos chat with Axel Merseburger, MD, PhD, Chairman of the Clinic of Urology at University Hospital Schleswig-Holstein in Lübeck, Germany, about his paper on continuing enzalutamide with docetaxel for the treatment of castration-resistant prostate cancer.